CAS: 28302-50-3

Methylammonium hexafluorophosphate is a synthetic chemical that inhibits the enzyme phosphodiesterase, which is responsible for the breakdown of cGMP. This inhibition leads to an increase in intracellular concentrations of cAMP and cGMP, which are important second messengers in cell signaling. Methylammonium hexafluorophosphate has shown therapeutic efficacy in treating various autoimmune diseases, cardiovascular disorders, and metabolic disorders. It also has potent pro-inflammatory effects and can be used as a catalyst to synthesize other chemicals.